Navigation Links
Breast Cancer Survivors Growing in Numbers

Approximately two million breast cancer survivors have been found to be alive in America today. Screening and treatment advances have helped in the longer management of the disease. //

However it has been estimated that about a third of these long-term survivors do suffer from debilitating fatigue making normal activities of life difficult to manage.

Researchers at the University of California at Los Angeles found that not all survivors suffer from fatigue. It was found that the blood of fatigued survivors contained an abnormally high level of proteins indicating that their immune inflammatory response was still working at full-tilt. Non-fatigued survivors did not have high levels of this protein.

According to Dr. Michael Irwin of UCLA’s Jonsson Cancer Center and lead author of the research ‘It appears there is an activation of the immune system that’s present and that probably occurs in the midst of treatment but in the women that have persistent fatigue, that immune activation, we hypothesize, that those women don’t turn off their immune system.’

The results of the study have been published in the May 1st issue of Clinical Cancer Research. Their study revealed that persistent fatigue was unrelated to the type of treatment received for the breast cancer nor was it related to the stage of her disease at diagnosis.

Instead the hypothesis of the researchers seemed to indicate that the brain and immune system get stuck in an endless feedback loop and immune proteins communicated with brain to keep the production of immune proteins turned on.

Dr. Irwin opined that the abnormally high level of anti-inflammatory proteins could easily be a “marker” to identify women at greater risk of developing persistent fatigue and thereby a need for additional support.

The researchers plan to investigate whether that endless feedback loop could be broken through mind-body disciplines and exercise tha t are safe and widely used.
'"/>




Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2016)... , ... February 13, 2016 , ... ... Outlook’s top Clinical Data Management Solution Providers list for its expertise in eClinical ... and domain expertise to serve the technology needs of global clients. DDi provides ...
(Date:2/12/2016)... Antonio, TX (PRWEB) , ... February 12, 2016 , ... ... love, as expressed in Blue SKies Buddha, the biography of Rama - Dr. Frederick ... fact a love story, the love of a Buddhist teacher for teaching and helping ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop the advanced skills needed to introduce ... from U.S. universities who will draw from Siemens’ deep knowledge of product ...
(Date:2/12/2016)... ... ... , Back to the Future , Feb. 25, 2016 — 11:00 a.m. – 12:30 p.m. ... learn from history are doomed to repeat it.” , An analysis of CDRH’s enforcement actions ... takes time. , Take a close look at the warning letters the agency sent ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Each year, the ... be held in Anaheim, CA at the Anaheim Convention Center. Almost 10,000 physical therapists ... new therapy products in action, learn more about their chosen field and network with ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Feb. 12, 2016  SI-BONE, Inc., a medical device company that ... a minimally invasive surgical (MIS) device indicated for fusion for certain ... Inc. (NGS), the Medicare Administrative Contractor (MAC) covering the states of ... Maine , Massachusetts , ... New York , Rhode Island , ...
(Date:2/12/2016)... SEOUL, South Korea , Feb. 12, 2016 ... today announced they will form a partnership to ... medicine in cancer. The goal of the collaboration ... with Macrogen,s high-throughput Next Generation Sequencing capabilities toward ... Laboratory Improvement Amendments (CLIA) of 1988 by the ...
(Date:2/12/2016)... 2016  Apellis Pharmaceuticals, Inc., today announced ... Series D preferred stock financing, co-led by ... Group and venBio Global Strategic Fund, joining ... Investment, and Epidarex Capital. The proceeds of the ... clinical trials in the Company,s ongoing complement ...
Breaking Medicine Technology: